- GlobeNewswire•4 days ago
ROCKVILLE, Md., April 26, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ...
- MarketWatch•11 days ago
Harry Boxer sums up what the charts are telling him about these four stocks.
- Investor's Business Daily•12 days ago
Shares of biotech leader Supernus Pharmaceuticals briefly broke out Tuesday, but struggled to remain above that key level of support.
SUPN : Summary for Supernus Pharmaceuticals, Inc. - Yahoo Finance
Supernus Pharmaceuticals, Inc. (SUPN)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||24.65 x 100|
|Ask||33.95 x 700|
|Day's Range||32.10 - 33.30|
|52 Week Range||14.14 - 33.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||18.56|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|